Mark Wang
About Mark Wang
Mark Wang is a Senior Scientist at Bristol Myers Squibb in New Brunswick, New Jersey, with extensive experience in analytical chemistry and forensic investigations in the pharmaceutical industry.
Current Position at Bristol Myers Squibb
Mark Wang currently holds the position of Sr. Scientist at Bristol Myers Squibb, located in New Brunswick, New Jersey, United States. In his role, he provides laboratory-based testing support and strategy for complex manufacturing investigations, product quality complaints, and third-party CMO investigations. His responsibilities also encompass commercial drug product analytical method development and validation activities.
Previous Experience at Celgene Corporation
Before joining Bristol Myers Squibb, Mark Wang worked at Celgene Corporation, where he served as a Sr. Scientist from 2018 to 2019 in New Jersey. Prior to that role, he worked as Scientist II at Celgene from 2015 to 2018 in Summit, New Jersey. His duties included supporting commercial drug product analytical method development and validation, ensuring compliance with cGMP/GLP, ICH, and USP regulations.
Education and Academic Background
Mark Wang's academic background includes a Master of Science (M.S.) in Computer Science from Virginia Polytechnic Institute and State University, completed in 2000. He also holds a Master of Science (M.S.) in Organic Mass Spectrometry from the Guangzhou Institute of Chemistry, Chinese Academy of Sciences, completed in 1994. Additionally, he earned a Bachelor of Arts (B.A.) in Analytical Chemistry from the East China Institute of Technology in 1991.
Expertise in Forensic Investigations
Mark Wang has extensive experience in forensic investigations involving the physical and chemical characterization of materials. This includes analyzing foreign and particulate matter in pharmaceutical products. His expertise extends to counterfeit pharmaceutical investigations using various analytical technologies and commercial reference standard qualification.
Experience in Quality Control and Project Management
Mark Wang has significant experience in Quality Control (QC) oversight of contract service providers (CSPs or CMOs). He has supervised contract scientists and managed various projects. His roles have often involved ensuring compliance with cGMP/GLP, ICH, and USP regulations, as well as supporting commercial drug product analytical method development and validation activities.